These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21186920)

  • 1. Role of progesterone in nicotine addiction: evidence from initiation to relapse.
    Lynch WJ; Sofuoglu M
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):451-61. PubMed ID: 21186920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of nicotine addiction: present therapeutic options and pipeline developments.
    Polosa R; Benowitz NL
    Trends Pharmacol Sci; 2011 May; 32(5):281-9. PubMed ID: 21256603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.
    Sofuoglu M; Mitchell E; Mooney M
    Hum Psychopharmacol; 2009 Oct; 24(7):559-64. PubMed ID: 19743227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline.
    Swalve N; Smethells JR; Carroll ME
    Behav Brain Res; 2016 Jul; 308():46-52. PubMed ID: 27091301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.
    Pfeffer D; Wigginton B; Gartner C; Morphett K
    Nicotine Tob Res; 2018 Aug; 20(9):1038-1046. PubMed ID: 29059355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.
    Higgins ST; Heil SH; Sigmon SC; Tidey JW; Gaalema DE; Hughes JR; Stitzer ML; Durand H; Bunn JY; Priest JS; Arger CA; Miller ME; Bergeria CL; Davis DR; Streck JM; Reed DD; Skelly JM; Tursi L
    JAMA Psychiatry; 2017 Oct; 74(10):1056-1064. PubMed ID: 28832876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse prevention interventions for smoking cessation.
    Livingstone-Banks J; Norris E; Hartmann-Boyce J; West R; Jarvis M; Hajek P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003999. PubMed ID: 30758045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in nicotine action.
    Pogun S; Yararbas G
    Handb Exp Pharmacol; 2009; (192):261-91. PubMed ID: 19184653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse prevention interventions for smoking cessation.
    Hajek P; Stead LF; West R; Jarvis M; Lancaster T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD003999. PubMed ID: 19160228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in vaccines against nicotine addiction].
    Wang GB; Zhu CJ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1189-94. PubMed ID: 24187824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory.
    Pang RD; Liautaud MM; Kirkpatrick MG; Huh J; Monterosso J; Leventhal AM
    Neuropsychopharmacology; 2018 Mar; 43(4):828-837. PubMed ID: 28905874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs used to treat nicotine addiction].
    Zieleń I; Sliwińska-Mossoń M; Milnerowicz H
    Przegl Lek; 2012; 69(10):1098-102. PubMed ID: 23421099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study.
    Forray A; Gilstad-Hayden K; Suppies C; Bogen D; Sofuoglu M; Yonkers KA
    Psychoneuroendocrinology; 2017 Dec; 86():96-103. PubMed ID: 28926762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial.
    Tosun NL; Fieberg AM; Eberly LE; Harrison KA; Tipp AR; Allen AM; Allen SS
    Addiction; 2019 Oct; 114(10):1800-1813. PubMed ID: 31059177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and smoking cessation improving outcomes in smokers at risk.
    Lerman CE; Schnoll RA; Munafò MR
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S398-405. PubMed ID: 18021915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine chemistry, metabolism, kinetics and biomarkers.
    Benowitz NL; Hukkanen J; Jacob P
    Handb Exp Pharmacol; 2009; (192):29-60. PubMed ID: 19184645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.
    Allenby CE; Boylan KA; Lerman C; Falcone M
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):471-83. PubMed ID: 26872457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
    Saladin ME; McClure EA; Baker NL; Carpenter MJ; Ramakrishnan V; Hartwell KJ; Gray KM
    Nicotine Tob Res; 2015 Apr; 17(4):398-406. PubMed ID: 25762749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving.
    Xue YX; Deng JH; Chen YY; Zhang LB; Wu P; Huang GD; Luo YX; Bao YP; Wang YM; Shaham Y; Shi J; Lu L
    JAMA Psychiatry; 2017 Mar; 74(3):224-232. PubMed ID: 28146250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian hormones, menstrual cycle phase, and smoking: a review with recommendations for future studies.
    Wetherill RR; Franklin TR; Allen SS
    Curr Addict Rep; 2016 Mar; 3(1):1-8. PubMed ID: 27134810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.